Author: Customer Service

Coloplast A/S – Interim Financial Report, Q1 2025/26

Written by Customer Service on February 6, 2026. Posted in Earnings Releases And Operating Results.

2025/26Interim financial results, Q1 2025/261 October 2025 – 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT growth1 in constant currencies of 3%. Reported revenue in DKK grew 0%, reflecting 4%-points negative impact from currencies. Return on invested capital2 was 15%. • Organic growth rates by business area: Ostomy Care 4%, Continence Care 7%, Voice & Respiratory Care 8%, Wound & Tissue Repair 5%, and Interventional Urology 8% .• Soft start in Ostomy Care, as expected, driven by negative growth in China and a high baseline in the US. The growth momentum is expected to pick up rest of year.• Growth in Continence Care was driven by continued strong contribution from Luja™ for both male and female users.• Voice & Respiratory Care growth was driven by good momentum in Laryngectomy, while...

Q4 and FY 2025 strong financial results: delivering on the roadmap and confirming PowerUp 2026 targets

Written by Customer Service on February 6, 2026. Posted in Earnings Releases And Operating Results.

2025 NET INCOME GROUP SHARE OF EUR 996 MILLION, UP 45.7% VS. EUR 684 MILLION IN 2024FULL YEAR 2025 RESULTS1 Leasing and Services margins at EUR 2,944 million, up 9.1% vs. 2024 Underlying margins2 at 565 bps of average earning assets vs. 532 bps in 2024Net used car sales (UCS) result3 at EUR 411 million up 29.6% vs. 2024. Net UCS result per unit at 1,075 EUR, at the high end of the guidanceSynergies4 at EUR 357 million, in line with guidance Cost to income ratio5 at 56.1% better than guidance and down 7.1 points vs. 63.2% in 2024 Return on Tangible Equity6 (ROTE) at 12.9% vs. 8.6% in 2024Earning assets7 at EUR 53.0 billion, down 1.0% vs. 2024Total proposed distribution for 2025 of EUR 1,150 million8CET1 ratio at 13.2% as at end 2025 Q4 2025 RESULTSLeasing and Services margins at EUR 747 million, up 10.7% vs. Q4 2024 Underlying margins...

DMG Blockchain Solutions Announces Receipt of $1.5 Million Energy Efficiency Incentive, January Preliminary Operational Results

Written by Customer Service on February 6, 2026. Posted in Public Companies.

VANCOUVER, British Columbia, Feb. 06, 2026 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG”), a leading vertically integrated blockchain and data center technology company, announces it has been awarded a $1.5 million energy efficiency incentive related to the deployment of hydro direct liquid cooled (DLC) server technology at its Christina Lake data center facility. This incentive was based on an energy efficiency study performed by an independent third party, which calculated a target energy savings for a given computational capacity using air-cooled technology and the resulting energy savings by converting to DLC. From the estimated savings and the budget to deploy the new cooling technology, an energy efficiency incentive was offered to encourage DMG’s investment in this...

Telenor reports strong results and announces NOK 15 billion share buyback programme

Written by Customer Service on February 6, 2026. Posted in Public Companies.

IMG_TEL-Q4-2025CFO Torbjørn Wist & CEO Benedicte Schilbred FasmerTelenor enters 2026 with strong Nordic growth, a solid financial position, and a simplified portfolio in line with the ambitions presented at the Capital Markets Day. “The results for 2025 show that we are delivering on our promises. We are entering 2026 with a simplified portfolio and strengthened financial capacity. I am very proud of the strong efforts of our employees throughout the year, how we continue to put our customers first every day and develop services that provide greater security and add value to people’s everyday lives,” says CEO Benedicte Schilbred Fasmer. Fourth quarter highlights:Service revenues of NOK 19.8 billion. Adjusted EBITDA of NOK 8.6 billion. Free cash flow before M&A of NOK 4.1 billion.Service revenues increased by 2.6...

Solid EBITDAaL growth slightly exceeding the 2025 guidance, supported by sustained commercial performance, synergies and efficiencies

Written by Customer Service on February 6, 2026. Posted in Public Companies.

Press releaseEmbargo until 6 February 2026 at 7:00 am Regulated information – Inside information Financial information for the second semester and full year 2025 Solid EBITDAaL growth slightly exceeding the 2025 guidance, supported by sustained commercial performance, synergies and efficienciesMobile postpaid customer base +2.5% yoy / Cable customer base +1.8% yoy H2 Revenues -1.5% yoy / FY 2025 Revenues -1.5% yoy H2 EBITDAaL +3.4% yoy / FY 2025 EBITDAaL +4.0% yoy H2 Operational HighlightsSolid commercial performance, combining value management on our premium brands and dynamic volume driven growth on hey! Mobile postpaid increased by 38k net adds over the semester, bringing total subscribers to 3.6m up by 2.5%. Our cable offers generated 5k net adds over the period, totalling 1,039k customers (+1.8%yoy) H2...

Clear route to registration positions lucerastat as the potential first oral therapy for all patients with Fabry disease

Written by Customer Service on February 6, 2026. Posted in Public Companies.

Allschwil, Switzerland – February 06, 2026Idorsia Ltd (SIX: IDIA) announces the design of its FDA-agreed Phase 3 registration program for lucerastat in Fabry disease. Building on the robust biomarker and renal findings from the MODIFY Phase 3 trial and its long‑term open-label extension (OLE), the program focuses on lucerastat’s impact on renal pathology – a central driver of morbidity and mortality in Fabry disease – with the goal of securing market authorization. Fabry disease is a rare, X-linked lysosomal storage disorder caused by mutations in the GLA gene that lead to deficient α-galactosidase A (α-GalA) activity and progressive accumulation of globotriaosylceramide (Gb3). Over time, Gb3 accumulation drives multisystem organ damage, primarily impacting the kidneys, heart, and nervous system. According to DelveInsight, approximately...

WeRide and Uber to Deploy 1,200 Robotaxis in the Middle East

Written by Customer Service on February 6, 2026. Posted in Public Companies.

SAN FRANCISCO and GUANGZHOU, China, Feb. 06, 2026 (GLOBE NEWSWIRE) — WeRide (NASDAQ: WRD, HKEX: 0800), a global leader in autonomous driving technology, and Uber Technologies, Inc. (NYSE: UBER) today announced a major expansion of their strategic partnership to deploy at least 1,200 Robotaxis across the Middle East. The deployment, which will span Abu Dhabi, Dubai, and Riyadh, is expected to be completed as soon as 2027.WeRide and Uber’s Robotaxi fleet in Abu Dhabi All 1,200 Robotaxis will be available through the Uber app in the three markets, following existing fully driverless commercial Robotaxi operations in Abu Dhabi and passenger operations in Dubai and Riyadh. The fleet will be scaled up progressively, with Uber committed to adding more Robotaxis as key regulatory approvals and performance milestones are met, including...

Societe Generale: Fourth quarter & 2025 full year results

Written by Customer Service on February 6, 2026. Posted in Earnings Releases And Operating Results.

RESULTS AT 31 DECEMBER 2025 Press release Paris, 6 February 2026 at 6:25 am RECORD REVENUES OF EUR 27.3BN IN 2025, +6.8%1 VS. 2024RECORD GROUP NET INCOME OF EUR 6BN IN 2025, +43% VS. 20242025 TOTAL DISTRIBUTION OF EUR 4.7BN, +169% VS. 20242026 ROTE TARGET UPGRADED TO MORE THAN 10%Record revenues of EUR 27.3bn in 2025, strongly up by +6.8% vs. 2024, excluding asset disposals, above the 2025 annual target of >+3% Costs down -2.0% vs. 2024, excluding asset disposals, better than the 2025 annual target of >-1% Cost-to-income ratio of 63.6% in 2025, below the 2025 annual target of +2% and reduction in costs of ~-3% vs. 2025, leading to a cost-to-income ratio of 100% NSFR 116% 117% >100% In EURbn 31/12/2025 31/12/2024 Total consolidated balance sheet 1,547 1,574 Shareholders’ equity (IFRS),...

Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

Written by Customer Service on February 6, 2026. Posted in Public Companies.

An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context, published pricing disclosures, telehealth eligibility considerations, and regulatory factors consumers are researching before choosing a GLP-1 weight loss provider San Francisco, California, Feb. 05, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. It is not medical advice. Weight management concerns should be evaluated by a qualified healthcare professional. Hims GLP-1 Weight Loss is a prescription-only medication program available exclusively through licensed physician consultation. This content does not diagnose, treat, cure, or prevent any disease. Prescription approval is not guaranteed. If you purchase through links in this article, a commission...

Ambarella Announces Fourth Quarter and Fiscal Year 2026 Earnings Conference Call to be Held February 26, 2026

Written by Customer Service on February 6, 2026. Posted in Public Companies.

SANTA CLARA, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced it will hold its fourth quarter and fiscal year 2026 earnings conference call on Thursday, February 26, 2026 at 1:30 p.m. (Pacific Time). The company will issue its earnings release after the market closes that same day. Those interested in asking a question on the call are required to register online in advance. Upon completing the first step of the online registration process, please note a registration verification code will be emailed to you, and this code must be entered to complete the online registration process. Once registered and verified, the dial-in numbers will be sent to the registered email with a personal identification number (PIN). When dialing in for the live call, the PIN number...

Author: Customer Service

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals